Jeet Mukherjee
Stock Analyst at BTIG
(4.41)
# 308
Out of 5,064 analysts
13
Total ratings
76.92%
Success rate
14.05%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Initiates: Buy | $26 | $9.37 | +177.48% | 1 | Nov 7, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $27 | $16.76 | +61.10% | 3 | Nov 4, 2025 | |
| ARVN Arvinas | Maintains: Buy | $10 → $14 | $11.52 | +21.53% | 2 | Oct 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $59 → $75 | $66.04 | +13.57% | 2 | Oct 22, 2025 | |
| CATX Perspective Therapeutics | Reiterates: Buy | $14 | $2.09 | +569.86% | 2 | Oct 13, 2025 | |
| MNPR Monopar Therapeutics | Maintains: Buy | $87 → $104 | $91.56 | +13.59% | 3 | Sep 25, 2025 |
Aardvark Therapeutics
Nov 7, 2025
Initiates: Buy
Price Target: $26
Current: $9.37
Upside: +177.48%
Nurix Therapeutics
Nov 4, 2025
Reiterates: Buy
Price Target: $27
Current: $16.76
Upside: +61.10%
Arvinas
Oct 30, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $11.52
Upside: +21.53%
Kymera Therapeutics
Oct 22, 2025
Maintains: Buy
Price Target: $59 → $75
Current: $66.04
Upside: +13.57%
Perspective Therapeutics
Oct 13, 2025
Reiterates: Buy
Price Target: $14
Current: $2.09
Upside: +569.86%
Monopar Therapeutics
Sep 25, 2025
Maintains: Buy
Price Target: $87 → $104
Current: $91.56
Upside: +13.59%